{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:46:11Z","timestamp":1783248371138,"version":"3.54.6"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["ynIIT2023009"],"award-info":[{"award-number":["ynIIT2023009"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2025NSCQ-GPX1075"],"award-info":[{"award-number":["CSTB2025NSCQ-GPX1075"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX1113"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX1113"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.drup.2026.101404","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:48:52Z","timestamp":1776440932000},"page":"101404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting keratin 6 A overcomes gemcitabine resistance by restoring equilibrative nucleoside transporter 1 and TAM-mediated metabolic compensation in pancreatic cancer"],"prefix":"10.1016","volume":"87","author":[{"given":"Junfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silue","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renpei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-2539","authenticated-orcid":false,"given":"Jianyou","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101404_bib1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1158\/0008-5472.CAN-24-1875","article-title":"Adenosine Uptake through the Nucleoside Transporter ENT1 Suppresses Antitumor Immunity and T-cell Pyrimidine Synthesis","volume":"85","author":"Allard","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101404_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15257770.2016.1210805","article-title":"Equilibrative nucleoside transporters-A review","volume":"36","author":"Boswell-Casteel","year":"2017","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.drup.2026.101404_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071978","article-title":"Depletion of Macrophages Improves Therapeutic Response to Gemcitabine in Murine Pancreas Cancer","volume":"12","author":"Buchholz","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2026.101404_bib4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2174\/0115680096260614231115192343","article-title":"CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells","volume":"24","author":"Cardenas","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.drup.2026.101404_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.694071","article-title":"KRT6A Promotes Lung Cancer Cell Growth and Invasion Through MYC-Regulated Pentose Phosphate Pathway","volume":"9","author":"Che","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.drup.2026.101404_bib6","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.scib.2024.06.016","article-title":"An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria","volume":"69","author":"Chen","year":"2024","journal-title":"Sci. Bull."},{"key":"10.1016\/j.drup.2026.101404_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-016-3003-0","article-title":"Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective","volume":"78","author":"Ciccolini","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.drup.2026.101404_bib8","article-title":"Metabolic reprogramming of tumor-associated macrophages via adenosine-A(2A)R signaling drives cross-resistance in non-small cell lung cancer","volume":"82","author":"Ding","year":"2025","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2026.101404_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.gastro.2008.09.067","article-title":"Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer","volume":"136","author":"Farrell","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2026.101404_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2200034","article-title":"Construction of inflammatory associated risk gene prognostic model of NSCLC and its correlation with chemotherapy sensitivity","volume":"55","author":"Gong","year":"2023","journal-title":"Ann. Med"},{"key":"10.1016\/j.drup.2026.101404_bib11","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1021\/nn301148e","article-title":"alpha(V)beta(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug","volume":"6","author":"Graf","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2026.101404_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-022-01587-9","article-title":"Hsa-miR-3178\/RhoB\/PI3K\/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer","volume":"21","author":"Gu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101404_bib13","article-title":"The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance","volume":"73","author":"Gu","year":"2024","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2026.101404_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111407","article-title":"Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1","volume":"127","author":"Guo","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.drup.2026.101404_bib15","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.cmet.2019.02.001","article-title":"Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer","volume":"29","author":"Halbrook","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.drup.2026.101404_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2024.102075","article-title":"Keratin 6A Is Expressed at the Invasive Front and Enhances the Progression of Colorectal Cancer","volume":"104","author":"Harada-Kagitani","year":"2024","journal-title":"Lab Invest"},{"key":"10.1016\/j.drup.2026.101404_bib17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/bdd.2131","article-title":"Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells","volume":"39","author":"Hioki","year":"2018","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.drup.2026.101404_bib18","article-title":"Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma","volume":"76","author":"Hong","year":"2024","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.drup.2026.101404_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.actbio.2023.07.008","article-title":"Targeted nanodelivery of siRNA against KRAS G12D inhibits pancreatic cancer","volume":"168","author":"Huang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.drup.2026.101404_bib20","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1038\/s41467-023-40457-w","article-title":"Characterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101404_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ijc.33304","article-title":"Stroma vs epithelium-enhanced prognostics through histologic stratification in pancreatic ductal adenocarcinoma","volume":"148","author":"Kalloger","year":"2021","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.drup.2026.101404_bib22","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1016\/j.cell.2021.07.020","article-title":"Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy","volume":"184","author":"Koikawa","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101404_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s43556-024-00241-8","article-title":"Cancer vaccines: platforms and current progress","volume":"6","author":"Lei","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.drup.2026.101404_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122290","article-title":"Chemotherapy-induced nanovaccines implement immunogenicity equivalence for improving cancer chemoimmunotherapy","volume":"301","author":"Li","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.drup.2026.101404_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41565-022-01098-0","article-title":"A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy","volume":"17","author":"Liu","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.drup.2026.101404_bib26","first-page":"128","article-title":"Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization","volume":"43","author":"Liu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.drup.2026.101404_bib27","doi-asserted-by":"crossref","DOI":"10.4143\/crt.2025.423","article-title":"Keratin 6A Overexpression in the Lymphovascular Invasion-Associated Tumor Subgroup Promotes Progression of Triple-Negative Breast Cancer","author":"Luo","year":"2025","journal-title":"Cancer Res Treat."},{"key":"10.1016\/j.drup.2026.101404_bib28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.gastro.2012.06.006","article-title":"Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma","volume":"143","author":"Mar\u00e9chal","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drup.2026.101404_bib29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2026.101404_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41565-024-01803-1","article-title":"Targeted intervention in nerve-cancer crosstalk enhances pancreatic cancer chemotherapy","volume":"20","author":"Qin","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.drup.2026.101404_bib31","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","article-title":"Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2\/CCR2 axis","volume":"19","author":"Sanford","year":"2013","journal-title":"Clin. Cancer Res. Official J. American Association Cancer Res."},{"key":"10.1016\/j.drup.2026.101404_bib32","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/cas.16175","article-title":"ECM1 and KRT6A are involved in tumor progression and chemoresistance in the effect of dexamethasone on pancreatic cancer","volume":"115","author":"Shinomiya","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.drup.2026.101404_bib33","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA a Cancer J Clini."},{"key":"10.1016\/j.drup.2026.101404_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020219","article-title":"Macrophage C\/EBP\u03b4 Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent Manner","volume":"10","author":"Spek","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.drup.2026.101404_bib35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2026.101404_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","article-title":"Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy","volume":"17","author":"Toledo","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101404_bib37","first-page":"308","article-title":"Cancer treatment and survivorship statistics, 2025","volume":"75","author":"Wagle","year":"2025","journal-title":"CA a Cancer J. Clin."},{"key":"10.1016\/j.drup.2026.101404_bib38","first-page":"30","article-title":"Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy","volume":"17","author":"Wang","year":"2024","journal-title":"Nanomicro Lett."},{"key":"10.1016\/j.drup.2026.101404_bib39","article-title":"mRNA Delivery of a Bispecific Single-Domain Antibody to Polarize Tumor-Associated Macrophages and Synergize Immunotherapy against Liver Malignancies","volume":"33","author":"Wang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2026.101404_bib40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-024-01613-x","article-title":"Consensus, debate, and prospective on pancreatic cancer treatments","volume":"17","author":"Wang","year":"2024","journal-title":"J. Hematol. & Oncol."},{"key":"10.1016\/j.drup.2026.101404_bib41","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/1535-7163.MCT-20-0316","article-title":"EMT-Induced Gemcitabine Resistance in Pancreatic Cancer Involves the Functional Loss of Equilibrative Nucleoside Transporter 1","volume":"20","author":"Weadick","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2026.101404_bib42","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1021\/acsnano.4c14969","article-title":"siRNA-Encapsulated Biomimetic Liposomes Effectively Inhibit Tumor Cells' Hexosamine Biosynthesis Pathway for Attenuating Hyaluronan Barriers to Pancreatic Cancer Chemotherapy","volume":"19","author":"Wu","year":"2025","journal-title":"ACS nano"},{"key":"10.1016\/j.drup.2026.101404_bib43","article-title":"CpG-Based Nanovaccines Enhance Ovarian Cancer Immune Response by Gbp2-Mediated Remodeling of Tumor-Associated Macrophages","volume":"12","author":"Xiong","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2026.101404_bib44","article-title":"Targeting tumor-associated CCR2(+) macrophages to inhibit pancreatic cancer recurrence following irreversible electroporation","volume":"11","author":"Xu","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2026.101404_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310984","article-title":"alphavbeta3 integrin-targeted magnetic resonance imaging in a pancreatic cancer mouse model using RGD-modified liposomes encapsulated with Fe-deferoxamine","volume":"19","author":"Yoshimoto","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2026.101404_bib46","article-title":"Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2026.101404_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308780","article-title":"NIR-II Photoacoustic Imaging-Guided Oxygen Delivery and Controlled Release Improves Photodynamic Therapy for Hepatocellular Carcinoma","volume":"36","author":"Zeng","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2026.101404_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125063","article-title":"Crude polysaccharide from Danggui Buxue decoction enhanced the anti-tumor effect of gemcitabine by remodeling tumor-associated macrophages","volume":"242","author":"Zhan","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.drup.2026.101404_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101317","article-title":"Metabolic basis of fatty acid oxidation and immunotherapy resistance with clinical perspectives","volume":"84","author":"Zhang","year":"2026","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2026.101404_bib50","article-title":"The role of the aging process and related factor EMP1 in promoting progression of resectable pancreatic cancer","volume":"12","author":"Zhang","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.drup.2026.101404_bib51","article-title":"A Noninvasive and Highly Effective Inhaled Nanovaccine Based on Natural Polysaccharide for Lung Cancer Treatment","volume":"37","author":"Zhang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2026.101404_bib52","article-title":"Multi-omics analysis reveals the chemoresistance mechanism of proliferating tissue-resident macrophages in PDAC via metabolic adaptation","volume":"42","author":"Zhang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2026.101404_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216457","article-title":"A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance","volume":"578","author":"Zhou","year":"2023","journal-title":"Cancer Lett."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:37:09Z","timestamp":1781062629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":53,"alternative-id":["S1368764626000555"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101404","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting keratin 6 A overcomes gemcitabine resistance by restoring equilibrative nucleoside transporter 1 and TAM-mediated metabolic compensation in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101404"}}